In the latest trading session, Medpace (MEDP) closed at $478.54, marking a +1.69% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. On the other hand, ...

In its recent Q4 results, Medpace Holdings reported revenue of US$708.5 million, a 32% year-on-year increase that surpassed analyst expectations by 3.3% and delivered the strongest growth and estimate ...

If you are wondering whether Medpace Holdings is still priced attractively after a strong multi year run, it helps to step back and look carefully at what the current share price implies about future ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Medpace is moving forward with an initial public stock offering, a filing that comes two years after a private equity firm acquired the contract research organization. Cincinnati-based Medpace aims to ...

Construction is underway on a 200,000-square-foot office building and parking garage for Medpace. Courtesy Medpace To continue reading this content, please enable ...

Medpace beats analyst estimates on the top and bottom lines in the fourth quarter. Medpace expects full-year 2025 revenue to be in the range of $2.11 billion to $2.21 billion. Up Next: Get 5 Dark ...

European private equity firm, Cinven, today announces a majority investment in Medpace, Inc. ('Medpace' or 'the Group'), a leading contract research organisation ('CRO'), for a total consideration of ...